Note: The transactions reported here refer to legal insider trading — purchases, sales, and other dealings in company securities by executives, directors, and major shareholders, which are required by law to be disclosed to the SEC via Form 4 filings within two business days of the transaction. This article covers the top 100 most significant transactions by dollar value from today's filings. This is entirely distinct from illegal insider trading, which involves buying or selling securities based on material, non-public information in violation of US federal securities law and equivalent legislation in other jurisdictions.
Today’s insider trading activity leaned heavily bearish, with sales significantly outpacing purchases. Out of 100 total trades, only 11 were buys, while 89 were sales, reflecting a cautious or profit-taking stance among corporate insiders. The disparity in volume and value underscores a broader trend of liquidity-seeking behavior, particularly among large shareholders and executives.
The most notable insider buys were concentrated in a handful of companies, with Gogoro Inc. (GGR) and Banco Bradesco S.A. (BBD) dominating the activity. Yin Chung-Yao, a director at Gogoro, made two separate purchases totaling $70.2 million, signaling strong confidence in the electric vehicle firm. Similarly, Banco Bradesco’s director, Rubens Aguiar Alvarez, invested $64 million across two transactions. GameStop (GME) also saw bullish activity, with CEO Ryan Cohen purchasing $22.8 million in shares, reinforcing his commitment to the company amid its ongoing transformation.
On the sell side, Eli Lilly and Company (LLY) and Medline Inc. (MDLN) saw the largest divestments. Lilly Endowment, Inc., a major shareholder in Eli Lilly, proposed sales worth $694.4 million across two filings, while GIC Private Ltd, a 10% owner of Medline, sold $549.6 million in shares. Palo Alto Networks (PANW) also featured prominently, with CEO Nikesh Arora proposing to sell $201.4 million in stock. These high-value sales suggest institutional and executive-level moves to lock in gains or rebalance portfolios.
Related Reading
Regulatory Developments→Market News→Bulls & Bears Outlook→The stark contrast between limited buying and widespread selling highlights a risk-off tone among insiders today. While select executives are doubling down on their companies, the broader trend leans toward profit-taking, potentially signaling caution ahead of earnings season or macroeconomic uncertainties. Track all insider trades in real time on the MarketsFN Insider Trading Tracker.
Top 10 Stocks — Insider Activity
Price Charts — Top 3 Stocks
LLY — Eli Lilly and Company
LLY — Eli Lilly and Company
MDLN — Medline Inc.
MarketsFN Insider Trading Tracker
Monitor all SEC Form 4 filings in real time — filter by company, role, transaction type and dollar value.
Source: SEC Form 4 filings. Updated twice daily.
